The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
基本信息
- 批准号:8843334
- 负责人:
- 金额:$ 316.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-02 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAcquired Immunodeficiency SyndromeAddressAffectAgingAmericasAreaArtsBaltimoreBudgetsClinicalCollaborationsCommunicable DiseasesCommunitiesComorbidityCritiquesDeveloping CountriesDevelopmentDisciplineDiseaseEducation and OutreachEpidemicFertilizationFundingGoalsGrantGrowthHIVHealth ResourcesInstitutionInternationalIntervention StudiesKnowledgeLeadershipLiquid substanceMedicalMentorsNIH Grants and ContractsNeurologyNursing SchoolsPrincipal InvestigatorProductivityPublic HealthPublic Health NursesPublic Health NursingPublic Health SchoolsRecruitment ActivityResearchResearch ActivityResearch PersonnelResearch Project GrantsResourcesSchool NursingSchoolsScienceStructureStudy SectionSubstance abuse problemTranscendUnderrepresented MinorityUniversitiesWorkbasecareerco-infectioncombatglobal healthinnovationmedical schoolsnext generationnovelpandemic diseaseprogramsresponseworking group
项目摘要
This is a revision of a new application to re-establish a Center for AIDS Research (CFAR) at the Johns
Hopkins University (JHU). The new CFAR is comprised of more than 180 investigators from across all
divisions of JHU and is based on a large portfolio of domestic and international HIV/AIDS research projects,
with a Research Funding Base of $85 million for 165 grants to 136 Principal Investigators. This submission
has been extensively revised on the basis of the critique of our 2010 application. We now propose six cores
and three scientific working groups that will provide s a productive platform for promoting collaboration and
synergy across the JHU HIV research community. The aims ofthe JHU CFAR are to 1) Enhance integration
and productivity of JHU HIV/AIDS research by promoting trans-disciplinary innovation and collaboration
across disciplines and university divisions; 2) Recruit new investigators into HIV/AIDS research to address
the growing need for knowledge in rapidly emerging areas that affect the AIDS epidemic, e.g., co-infections,
co-morbidities, substance abuse, and aging; 3) Provide mentoring forth next generation of HIV/AIDS
researchers and to recruit underrepresented minority investigators through mentoring and developmental
grants; and 4) Mobilize the capacity of JHU to combat the HIV epidemic in Baltimore through engagement,
training, outreach and community-based intervention studies. These aims will be addressed across three
broad themes: Development and Mentoring of New Investigators, Addressing the Baltimore HIV Epidemic,
and Strengthening International Collaborations. We have garnered institutional commitments of $450,000
per year from the Provost and Deans of the medical, public health and nursing schools and $600,000 for
leveraging recruitment of HIV investigators from Departments. This new CFAR represents a major
commitment of investigators and institutional leadership to promote excellence, productivity and growth of
HIV research and control efforts at JHU, in Baltimore and globally.
这是对约翰斯重新建立艾滋病研究中心(CFAR)的新申请的修订
霍普金斯大学(JHU)。新的CFAR由来自所有人的180多名调查员组成
JHU的划分,并基于大量的国内和国际艾滋病毒/艾滋病研究项目组合
165个首席调查员的研究资助基础为165赠与了8500万美元。此提交
根据对我们2010年申请的批评进行了广泛的修订。我们现在建议六个核心
以及三个科学工作组,将为促进协作和
JHU HIV研究社区的协同作用。 JHU CFAR的目的是1)增强整合
通过促进跨学科创新与协作,JHU HIV/AIDS研究的生产力
跨学科和大学分界; 2)招募新的研究人员参加艾滋病毒/艾滋病研究以解决
在影响艾滋病流行的快速新兴地区对知识的需求日益增长的需求,例如共同感染,
合并症,药物滥用和衰老; 3)提供下一代艾滋病毒/艾滋病的指导
研究人员并通过指导和发展招募代表性不足的少数群体调查员
赠款; 4)动员JHU通过参与来对抗巴尔的摩的艾滋病毒流行的能力,
培训,外展和基于社区的干预研究。这些目标将在三个
广泛的主题:新调查人员的发展和指导,针对巴尔的摩艾滋病毒流行病,
并加强国际合作。我们已经获得了45万美元的机构承诺
每年从医学,公共卫生和护理学校的教务长和院长那里获得的,60万美元
利用部门招募艾滋病毒调查人员。这个新的CFAR代表了一个专业
调查人员和机构领导的承诺,以促进卓越,生产力和增长
艾滋病毒在巴尔的摩和全球的JHU进行研究和控制工作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard E. Chaisson其他文献
Efficacy of Engineering Controls in Reducing Occupational Exposure to Aerosolized Pentamidine
- DOI:
10.1378/chest.102.6.1764 - 发表时间:
1992-12-01 - 期刊:
- 影响因子:
- 作者:
Melissa A. McDiarmid;John Schaefer;Cindy Lynn Richard;Richard E. Chaisson;Byron S. Tepper - 通讯作者:
Byron S. Tepper
The Impact of Prophylaxis on Outcome and Resource Utilization in <em>Pneumocystis carinii</em> Pneumonia
- DOI:
10.1378/chest.107.4.1018 - 发表时间:
1995-04-01 - 期刊:
- 影响因子:
- 作者:
Joel E. Gallant;Sharon M. McAvinue;Richard D. Moore;John G. Bartlett;David L. Stanton;Richard E. Chaisson - 通讯作者:
Richard E. Chaisson
Richard E. Chaisson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard E. Chaisson', 18)}}的其他基金
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
JHU TRAC:培训和支持下一代结核病研究人员
- 批准号:
10431020 - 财政年份:2022
- 资助金额:
$ 316.19万 - 项目类别:
JHU TRAC: Training and Supporting the Next Generation of TB Researchers
JHU TRAC:培训和支持下一代结核病研究人员
- 批准号:
10593142 - 财政年份:2022
- 资助金额:
$ 316.19万 - 项目类别:
The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
- 批准号:
10268586 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10226377 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10413161 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防 HIV 未感染者结核病的安全性和耐受性
- 批准号:
10631078 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
超短疗程利福喷丁和异烟肼 (1HP) 用于预防未感染 HIV 个体结核病的安全性和耐受性
- 批准号:
10018455 - 财政年份:2020
- 资助金额:
$ 316.19万 - 项目类别:
The Johns Hopkins Center for AIDS Research (JHU CFAR)
约翰霍普金斯大学艾滋病研究中心 (JHU CFAR)
- 批准号:
9322787 - 财政年份:2012
- 资助金额:
$ 316.19万 - 项目类别:
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 316.19万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 316.19万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 316.19万 - 项目类别:
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
用于治疗 HIV 诊所兴奋剂使用的 reSET:护理优化支持治疗依从性 (COSTA)
- 批准号:
10553554 - 财政年份:2022
- 资助金额:
$ 316.19万 - 项目类别: